Identifiers | |
---|---|
IUPAC name
| |
CAS Number | |
Chemical and physical data | |
Formula | C21H24N4O4 |
Molar mass | 396.447 g·mol |
3D model (JSmol) | |
SMILES
| |
InChI
|
Methylenedioxynitazene (3',4'-Methylenedioxynitazene) is a benzimidazole derivative which has been sold as a designer drug over the internet and presumably has opioid effects. It is an analogue of etonitazene where the benzyl ring is substituted with a 3,4-methylenedioxy ring system rather than an ethoxy group. It was first reported in the UK in early 2024.
See also
References
- "Fourth addendum to ACMD report on the use and harms of 2-benzyl benzimidazole ('nitazene') and piperidine benzimidazolone ('brorphine-like') opioids" (PDF). Advisory Council on the Misuse of Drugs. 5 April 2024.
This analgesic-related article is a stub. You can help Misplaced Pages by expanding it. |